Australia's largest stock trading and investment forum Australia's #1 stock forum

FIREBRICK PHARMA LIMITED

2.70%

7.2¢

Market Cap $16.16M

Healthcare Biotechnology

Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on... Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on developing and commercializing novel formulations and uses of povidone-iodine. After more than 10 years of R&D including multiple human clinical trials, Firebrick's first product, Nasodine® Nasal Spray, is now available for sale in USA and Singapore.More

Recently Updated

Corporate Spotlight

Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on developing and commercializing novel formulations and uses of povidone-iodine. After more than 10 years of R&D including multiple human clinical trials, Firebrick's first product, Nasodine® Nasal Spray, is now available
View the full Corporate Spotlight

FIREBRICK PHARMA - JUNE INVESTOR WEBINAR

Latest Threads

Tag

Subject

Nasodine to a captive market

14/06/25

5

1.2K

14/06/25

Last post rae915

5

1.2K

Firebrick Pharma - June Investor Webinar

11/06/25

0

204

11/06/25

Last post

TheMarketOnline

0

204

Firebrick Pharma - Investor Webinar Live at 9am AWST/ 11am AEST

10/06/25

2

590

10/06/25

Last post

FirebrickPharma

2

590

Study spruiks Firebrick's Nasodine spray as 'effective treatment for common cold'

10/06/25

1

492

10/06/25

Last post Starlink

1

492

Buying Nasodine in Australia

10/06/25

29

7.7K

10/06/25

Last post

FirebrickPharma

29

7.7K

Ann: Nasodine Phase 3 Common Cold Trial Published

10/06/25

0

604

10/06/25

Last post

ASX News

0

604

Ann: Trading Halt

06/06/25

19

3.9K

06/06/25

Last post Mayi

19

3.9K

Ann: Withdrawal of Share Placement

06/06/25

0

393

06/06/25

Last post

ASX News

0

393

FRE - General Discussion

28/05/25

5

1.6K

28/05/25

Last post SurfBeach73

5

1.6K

One place for all answers about Firebrick

26/05/25

2

601

26/05/25

Last post

FirebrickPharma

2

601

Nasodine wins Guardian award in Singapore

20/05/25

1

486

20/05/25

Last post thestoicinvestors

1

486

Loan to purchase shares

17/05/25

7

1.9K

17/05/25

Last post Starlink

7

1.9K

Dear Dr Peter M - asx challenges with US market volatility

07/05/25

5

2.2K

07/05/25

Last post SurfBeach73

5

2.2K

Price Prediction ( 10 cents in March ) ???

24/04/25

49

17K

24/04/25

Last post SurfBeach73

49

17K

'Expansion' the watchword in Firebrick's sales-heavy quarter

16/04/25

1

593

16/04/25

Last post thestoicinvestors

1

593

Ann: March 2025 Quarterly Activity Report & Appendix 4C

16/04/25

1

909

16/04/25

Last post

FirebrickPharma

1

909

See All Discussions

Corporate Spotlight

Timeline

Nasodine Phase 3 Common Cold Trial Published
10 Jun 08:38	Share

Withdrawal of Share Placement
06 Jun 16:58	Share

Trading Halt
05 Jun 09:09	Share

March 2025 Quarterly Activity Report & Appendix 4C
16 Apr 10:56	Share

Cleansing Notice
28 Mar 14:58	Share

Application for quotation of securities - FRE
28 Mar 14:56	Share

Cleansing Notice
21 Mar 15:33	Share

Application for quotation of securities - FRE
21 Mar 15:32	Share

Becoming a substantial holder - Pharma Nutria NA Inc
06 Mar 12:02	Share

Becoming a substantial holder - Firebrick Pharma
06 Mar 10:08	Share

Change in substantial holding - Stephen Goodall
06 Mar 10:07	Share

Change in substantial holding - Peter Molloy
06 Mar 10:06	Share

Cleansing Notice
05 Mar 11:06	Share

Application for quotation of securities - FRE
05 Mar 11:04	Share

Proposed issue of securities - FRE
04 Mar 09:12	Share

FRE secures Strategic Investment from Philippines Partner
04 Mar 09:11	Share

Trading Halt
28 Feb 09:23	Share

Webinar on Firebrick Half-Year Results and 2025 Plans
20 Feb 15:40	Share

Appendix 4D & Half-Year Financial Report to 31 December 2024
20 Feb 15:20	Share

Nasodine to be Launched in Fiji and South Pacific
12 Feb 08:52	Share

December 2024 Quarterly Activity Report & Appendix 4C
23 Jan 08:36	Share

Successful Nasodine Patent Defense in Singapore
13 Jan 17:29	Share

Notification regarding unquoted securities - FRE
20 Dec 09:24	Share

Proposed issue of securities - FRE
19 Dec 09:22	Share

Consulting Agreement Extended to Grow Asia Sales
19 Dec 08:29	Share

Results of Annual General Meeting
27 Nov 15:38	Share

Annual General Meeting Presentation
27 Nov 09:05	Share

Nasodine Retail Pharmacy Launch in Singapore
25 Nov 08:22	Share

Nasodine COVID-19 Patent Allowed in Mexico
01 Nov 09:37	Share

Agreement Signed to Market Nasodine to HCPs in Singapore
31 Oct 08:41	Share

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 7.2¢		Change -0.002(2.70%)		Mkt cap ! $16.16M

Open	High	Low	Value	Volume
7.9¢	7.9¢	7.2¢	$1.645K	22.43K

Buyers (Bids)

No.	Vol.	Price($)
1	14675	7.2¢

Sellers (Offers)

Price($)	Vol.	No.
8.0¢	47101	2

View Market Depth

No.	Vol.	Price($)
1	14675	0.072
4	240200	0.070
2	13120	0.068
1	30000	0.062
2	70000	0.061

Price($)	Vol.	No.
0.080	47101	2
0.088	5758	2
0.090	200100	3
0.091	948112	2
0.092	2476	1

Last trade - 14.10pm 13/06/2025 (20 minute delay)

FRE (ASX) Chart